e-learning
resources
Milan 2017
Sunday, 10.09.2017
Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The prevalence of QTc-prolongation increase by GOLD stage in COPD
U. Nilsson (UMEÅ, Sweden)
Source:
International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Session:
Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Session type:
Poster Discussion
Number:
1568
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Nilsson (UMEÅ, Sweden). The prevalence of QTc-prolongation increase by GOLD stage in COPD. 1568
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
GOLD stage 0 and risk of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 352s
Year: 2003
The effect of changing GOLD severity stage on long-term mortality in COPD
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
High prevalence of osteoporosis in COPD patients independent of GOLD stage
Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010
Year: 2010
Physician-diagnosed COPD GOLD stage IV in Östersund, Sweden: prevalence and patient characteristics
Source: Eur Respir J 2006; 28: Suppl. 50, 447s
Year: 2006
Prevalence and severity of GOLD defined COPD in adults
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002
GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
COPD GOLD stage 1: Is it really a disease?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines
Source: Eur Respir J 2003; 22: Suppl. 45, 578s
Year: 2003
Ventilation-perfusion imbalance and GOLD stages in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 407s
Year: 2006
Validation of non-spirometric predictors of COPD to the GOLD stage classification
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002
GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Impact of comorbidities on survival of patients with COPD according to GOLD stages
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011
Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT?
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
High risk COPD patients cost less if treated according to GOLD 2011 recommendations
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
COPD GOLD classification in patients with COPD-OSA overlap syndrome
Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea
Year: 2020
Impact of symptomatology in patients with GOLD stage I COPD
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010
Effect of COPD severity on hemodynamic responses to exercise in patients with GOLD stages I-IV
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept